InsidersTradesSigma
Follow the 와이바이오로직스 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 와이바이오로직스 has logged 8 insider filings. Market capitalisation: €128.2bn. The latest transaction was reported on 1 July 2026 (Purchase). Among the most active insiders: 박영우. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
와이바이오로직스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biopharmaceutical products.